Literature DB >> 30311706

Striking cessation of cataplexy by opioids.

Claire E H M Donjacour1,2, Gert Jan Lammers3,2, Jerome M Siegel4.   

Abstract

Entities:  

Year:  2018        PMID： 30311706      PMCID： PMC8086822          DOI： 10.1111/jsr.12781

Source DB:  PubMed          Journal:  J Sleep Res        ISSN： 0962-1105            Impact factor:   3.981


× No keyword cloud information.
  6 in total

1.  Successful suppression of cataplectic attacks with tramadol.

Authors:  Adam Wichniak; Hans Brunner; Elisabeth Friess; Thomas Pollmächer
Journal:  Neurology       Date:  2003-09-23       Impact factor: 9.910

Review 2.  Pharmacological aspects of human and canine narcolepsy.

Authors:  S Nishino; E Mignot
Journal:  Prog Neurobiol       Date:  1997-05       Impact factor: 11.685

3.  Gelineau's narcolepsy relieved by opiates.

Authors:  J M Harper
Journal:  Lancet       Date:  1981-01-10       Impact factor: 79.321

4.  Effective treatment of narcolepsy with codeine in a patient receiving hemodialysis.

Authors:  S R Benbadis
Journal:  Pharmacotherapy       Date:  1996 May-Jun       Impact factor: 4.705

5.  Treatment of narcolepsy with codeine.

Authors:  J M Fry; M R Pressman; M A DiPhillipo; M Forst-Paulus
Journal:  Sleep       Date:  1986       Impact factor: 5.849

6.  Opiates increase the number of hypocretin-producing cells in human and mouse brain and reverse cataplexy in a mouse model of narcolepsy.

Authors:  Thomas C Thannickal; Joshi John; Ling Shan; Dick F Swaab; Ming-Fung Wu; Lalini Ramanathan; Ronald McGregor; Keng-Tee Chew; Marcia Cornford; Akihiro Yamanaka; Ayumu Inutsuka; Rolf Fronczek; Gert Jan Lammers; Paul F Worley; Jerome M Siegel
Journal:  Sci Transl Med       Date:  2018-06-27       Impact factor: 17.956
  6 in total
  1 in total

1.  Hypocretin/Orexin Interactions with Norepinephrine Contribute to the Opiate Withdrawal Syndrome.

Authors:  Ronald McGregor; Ming-Fung Wu; Brent Holmes; Hoa Anh Lam; Nigel T Maidment; Joseph Gera; Akihiro Yamanaka; Jerome M Siegel
Journal:  J Neurosci       Date:  2021-12-01       Impact factor: 6.709
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.